A dermoid cyst, medically known as a mature cystic teratoma, is a benign germ cell tumor of the ovary containing a variety of fully differentiated tissue types — including fat, hair, teeth, bone, skin glands, and occasionally thyroid or neural tissue. Dermoids are one of the most common ovarian tumors in young women and are almost always benign, but they grow continuously, carry a meaningful risk of ovarian torsion, and typically require surgical removal once identified.
Dermoid cysts are the most distinctive of all ovarian masses on imaging — the presence of fat signal on MRI is essentially pathognomonic and immediately differentiates them from endometriomas, cystadenomas, and hemorrhagic functional cysts, which can all appear similar on ultrasound. Despite their benign nature, dermoids must be managed carefully — they are the most common cause of ovarian torsion among ovarian tumors, and the rare malignant transformation to squamous cell carcinoma or the separate entity of immature teratoma must be excluded pathologically. The 10–15% bilateral rate means the contralateral ovary always requires evaluation at the time of surgery.
Causes
Germ cell origin.
Dermoid cysts arise from a single primordial germ cell within the ovary — the same cells that would normally develop into oocytes. Germ cells are unique in containing the full genomic and developmental capacity to produce all three primary tissue layers of the body: ectoderm (skin, hair, neural tissue, teeth), mesoderm (fat, muscle, cartilage, bone), and endoderm (thyroid, respiratory and gastrointestinal epithelium). When one of these cells undergoes parthenogenetic activation — beginning to divide and differentiate without fertilization — it produces a tumor that reflects this totipotential capacity, growing a disorganized but mature collection of tissues from all three germ layers. The result is a cyst whose interior may contain mature keratinized skin with hair follicles lining its wall, a "Rokitansky nodule" or dermoid plug containing teeth, calcification, and sebaceous material, floating fat, and hair — a collection of tissues that is simultaneously grotesque and biologically fascinating, and entirely benign in its mature cystic form.
Other contributing factors.
The trigger for germ cell parthenogenetic activation is not known. Dermoids are the most common ovarian tumor in women under age 30 and account for approximately 20–25% of all ovarian neoplasms. They occur most commonly between ages 20 and 40 but can develop at any age — including in young girls, where they represent the most common ovarian neoplasm of childhood, and occasionally in postmenopausal women. Approximately 10–15% of women with a dermoid have bilateral dermoids — one in each ovary — necessitating bilateral ovarian evaluation at the time of surgery. Growth rates are generally slow (1–2 mm per year on average), but unpredictable acceleration can occur.
Symptoms
The majority of dermoid cysts are asymptomatic and discovered incidentally on pelvic ultrasound, CT, or MRI performed for an unrelated indication. When symptoms develop, they typically include dull pelvic or abdominal discomfort, a sensation of fullness or pressure, and rarely pain with intercourse. Larger dermoids may produce a palpable lower abdominal mass.
The most clinically significant complication — and the primary reason dermoids require surgical removal — is ovarian torsion. Dermoids predispose to torsion more than other ovarian cysts because they are dense (fat and calcified content) and create an eccentric center of gravity that destabilizes the ovary's position on its ligamentous attachments, causing the ovary to rotate on its vascular pedicle. Torsion presents as sudden, severe, unilateral pelvic pain — often accompanied by nausea and vomiting — and requires emergency surgical detorsion within hours to preserve ovarian viability. Cyst rupture releases sebaceous material, hair, and keratin into the peritoneal cavity, producing chemical peritonitis (granulomatous reaction to sebum) that can cause severe inflammation and adhesion formation — a complication that must be meticulously managed during laparoscopic removal by careful avoidance of intracorporeal spillage. Malignant transformation within a dermoid — most commonly to squamous cell carcinoma — occurs in less than 2% of cases and is more common in older women and larger cysts.
Diagnosis
Pelvic ultrasound often provides the initial diagnosis, showing a cyst with characteristic mixed echogenicity — hyperechoic sebaceous material, shadowing from calcifications or teeth ("tip of the iceberg" sign), and a fluid-fat level ("dermoid mesh" or "hair-fluid interface"). These ultrasound features are highly suggestive but not always definitive, particularly for smaller or atypical cysts.
An MRI of the pelvis is the most accurate confirmatory study and is effectively diagnostic when fat signal is identified within the mass. On MRI, the fat component of a dermoid appears as T1-hyperintense (bright) signal that disappears — "drops out" — on fat-saturated sequences, confirming the lipid nature of the content. This fat signal is the unique MRI signature of a dermoid and distinguishes it from all other ovarian masses, including endometriomas (T1-bright but fat-saturated signal persists) and hemorrhagic cysts (T1-bright but loses signal on fat-suppressed T1 in subacute phase). The Rokitansky nodule — a mural soft tissue protuberance within the cyst — is the most common site of malignant transformation and is carefully evaluated on MRI for any solid enhancing components, restricted diffusion on DWI, or disproportionate soft tissue bulk that would raise concern for immature teratoma or malignant transformation. MRI also defines the cyst's size and relationship to the ovarian cortex for surgical planning, and evaluates the contralateral ovary for a second dermoid.
Classification
Teratomas are classified by the maturity of their tissue content and their behavior, spanning a spectrum from entirely benign to highly malignant.
- Mature cystic teratoma (dermoid cyst): The typical, almost universally benign form containing fully differentiated, adult-type tissues from all three germ layers. Accounts for over 95% of ovarian teratomas. Fat signal on MRI is diagnostic. Surgical removal is curative.
- Immature teratoma: Rare malignant form containing incompletely differentiated, embryonic-type neuroepithelial tissue. Occurs predominantly in adolescents and young women. Graded 1–3 by the proportion of immature neural elements present. Treated with surgery and chemotherapy. MRI shows large, complex, partially solid pelvic mass without the fat signal of mature dermoids.
- Monodermal teratoma: Highly specialized teratoma composed predominantly of a single tissue type. Struma ovarii — ovarian thyroid tissue — can cause hyperthyroidism and is identified by thyroid-signal tissue on MRI. Carcinoid teratoma can cause carcinoid syndrome. Rare but important to recognize.
- Dermoid with malignant transformation: Development of carcinoma (most commonly squamous cell carcinoma) within a previously benign dermoid. Occurs in less than 2% of dermoids, more often in large cysts (>10 cm) and in older women. Suspected when MRI shows an enlarging solid component with enhancement and restricted diffusion within an otherwise typical dermoid.
Treatments
Most dermoid cysts are managed surgically because they do not resolve spontaneously, grow over time, and carry the risks of torsion, rupture, and rare malignant transformation. The timing and approach are guided by cyst size, growth rate, symptoms, and patient age.
Surgical removal (laparoscopic cystectomy): Laparoscopic ovarian cystectomy — removing the dermoid while preserving as much healthy ovarian cortex and primordial follicles as possible — is the standard of care for premenopausal women, particularly those wishing to preserve fertility. The critical technical principle is avoiding intraoperative cyst rupture and intracorporeal spillage: the cyst is carefully dissected free, placed in a sealed laparoscopic bag (endobag), and removed intact through a port site. If spillage does occur, thorough peritoneal lavage is performed to minimize chemical peritonitis from sebaceous contents. Simultaneous examination and palpation of the contralateral ovary is performed, and any second dermoid is addressed at the same operation. A contralateral dermoid too small to safely cystect may be left in place and monitored with serial imaging.
Oophorectomy.
Removal of the entire affected ovary is appropriate for very large dermoids where insufficient healthy cortex remains to justify cystectomy, in postmenopausal women where ovarian preservation is less critical, or when the intraoperative frozen section raises concern for malignant transformation requiring oncologic staging. The contralateral ovary is inspected and palpated for a second dermoid during the same procedure.
Observation.
In carefully selected patients — particularly postmenopausal women with small (under 5 cm), clearly benign MRI features and significant surgical comorbidities — imaging surveillance every 6–12 months may be a reasonable alternative to immediate surgery. This approach accepts the slow growth rate of most dermoids and the very low malignant transformation risk in small cysts. Any growth, symptom development, or change in imaging character prompts surgical reassessment.
Pathology and follow-up.
Every removed dermoid is examined histologically to confirm mature differentiation and exclude immature or malignant elements — a proportion of dermoids that appear benign on imaging contain foci of immature neural tissue or early malignant transformation detectable only microscopically. Most women require no long-term follow-up after removal of a confirmed benign mature dermoid. The contralateral ovary should be monitored with periodic ultrasound or MRI for the development of a new dermoid, given the 10–15% bilateral rate.
Get an MRI to Confirm Your Diagnosis
Before surgical planning or starting treatment, a clear MRI diagnosis ensures the right path forward. First Look MRI offers self-pay Pelvis MRI scans — no doctor's order or insurance required — at our locations in Georgia, Texas, and Colorado.